Zimbabwe has declined a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of the United States' request for confidential information.
This move was revealed following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesperson has since stated that the US was seeking health data for scientific study and profit while was unwilling to guarantee the benefits from future vaccines.
"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more talks to secure a agreement suitable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision comes after a similar case in Kenya, where a high court blocked a related deal with the US following concerns were raised about the safety of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and accountability.
According to reports, Sixteen nations in Africa have to date agreed to similar health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to provide its biological resources and data over an extended period, with no corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our nation would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our population should a new health crisis emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems already established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage potential global health emergencies.
"This mechanism is intended to ensure that when a country contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to further discussions with our American counterparts on how future co-operation could be arranged in a manner that respects the independence and interests of both nations."
Medical Community Response
A leading public health body stated it understood the official position, but suggested that talks must proceed given that much of the country's Aids initiatives relied on external financing.
"If specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it added.
The halted deal emphasises the complex debate between receiving vital international aid and safeguarding a country's data in an ever more interconnected world.